Share Prices & Company Research

Stockbroking

Puretech Health Plc

Current Price 138.20p Bid 136.80p Ask 141.60p Change 5.66%
Last Updated: 25/05/2026 10:18. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Financial Highlights Year Ended 31/12/2025

Revenue
£4.66m
Operating Profit/Loss
£-98.53m
Dividend yield (%)
n/a
Total dividend for year
$n/a
Dividend cover
n/a
P/E Ratio
n/a
More Financials

Key Personnel

Dr. John LaMattina
Independent Non-Executive Director
Mr Michele Holcomb
Independent Non-Executive Director
Ms Kiran Mazumdar Shaw
Independent Non-Executive Director
Ms Sharon Barber-Lui
Independent Non-Executive Director
Mr Robert Lyne
Interim CEO
Dr. Robert Langer
Non-Executive Director
Mr H. Robert Horvitz
Non-Executive Director

Stock Details

EPIC
PRTCL
ISIN
GB00BY2Z0H74
Shares in Issue
237.39m
Market cap
£328.07m

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
138.20p
Bid Price
136.80p
Ask Price
141.60p
Volume
63,709
Change Today
7.40p
% Change Today
5.66%
Open
134.40p
Previous Close
138.20p
Intraday High
138.90p
Intraday Low
133.40p
52 Week High
146.20p
52 Week Low
105.80p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2025
31 Dec 2024
 
$ (M)
$ (M)
Continuing Operations
Revenue
4.66
4.66
Operating Profit/Loss
-98.53
-136.09
Net Interest
-32.73
4.77
Pre-Tax Profit
-110.93
23.77
Profit After Tax from continuing operations
-110.08
27.78
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-110.08
27.78
Attributable to:
Equity Holders of Parent Company
-109.74
53.51
Minority Interests
-0.35
-25.73
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2025
31 Dec 2024
Basic
-46.00c
21.00c
Diluted
-46.00c
21.00c
Adjusted
-46.00c
21.00c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2025
31 Dec 2024
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
11.50
15.13
Intangible Assets
0.60
0.60
Investment Properties
n/a
n/a
Investments
217.43
200.17
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.17
0.47
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
1.76
1.52
Cash at Bank & In Hand
252.47
280.64
Current Asset Investments
36.25
98.05
Other Current Assets
14.54
6.05
Other Assets
n/a
n/a
Total Assets
534.71
602.64

Liabilities

Year End Date
31 Dec 2025
31 Dec 2024
 
$ (M)
$ (M)
Current Liabilities
Borrowings
8.50
7.69
Other Current Liabilities
37.81
33.70
Total Current Liabilities
46.31
41.39
Non-Current Liabilities
Borrowings
11.09
14.67
Provisions
n/a
n/a
Other Non-Current Liabilities
171.64
138.64
Total Non-Current Liabilities
182.73
153.31
Other Liabilities
n/a
n/a
Total Liabilities
229.03
194.70

Net Assets

Year End Date
31 Dec 2025
31 Dec 2024
 
$ (M)
$ (M)
Net Assets
305.67
407.93

Capital & Reserves

Year End Date
31 Dec 2025
31 Dec 2024
 
$ (M)
$ (M)
Share Capital
4.86
4.86
Share Premium Account
290.26
290.26
Other Reserves
94.18
87.10
Retained Earnings
-77.23
32.49
Shareholders Funds
312.07
414.71
Minority Interests/Other Equity
-6.40
-6.77
Total Equity
305.67
407.93

Dividend History

Dividend Metrics

Year End Date
31 Dec 2025
31 Dec 2024
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.